Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» No Product Revenues, Plenty of Risk: Buy Exelixis?
No Product Revenues, Plenty of Risk: Buy Exelixis?
No Product Revenues, Plenty of Risk: Buy Exelixis?
Submitted by
admin
on November 9, 2009 - 9:58am
Source:
CNBC
News Tags:
Exelixis
GSK
Bristol-Myers Squibb
Sanofi
Roche
Genentech
Headline:
No Product Revenues, Plenty of Risk: Buy Exelixis?
Do Not Allow Advertisers to Use My Personal information
